Stefan Schreier1, Suparerk Borwornpinyo2, Rachanee Udomsangpetch3, Wannapong Triampo1,4. 1. Department of Physics, Faculty of Science, Mahidol University, Ratchathewi District, Bangkok, Thailand. 2. Department of Biotechnology, Faculty of Science, Mahidol University, Ratchathewi District, Bangkok, Thailand. 3. Faculty of Medical Technology, Mahidol University, Nakorn Pathom, Thailand. 4. Thailand Center of Excellence in Physics, CHE, Bangkok, Thailand.
Abstract
BACKGROUND: Circulating rare cells (CRCs) are benign or malignant minuscule events in the peripheral blood or other bodily fluids. The detection and quantification of certain CRC types is an invaluable or proposed candidate biomarker for diagnosis, prognosis and prediction of various pathological conditions. The list of CRC types and biomarker applicability thereof continues to expand along with improvements in cell selection technology. Past findings may suggest commonness of healthy donor peripheral blood circulating mature erythroblasts. This work suggests the occurrence of morphologically distinct bone marrow native circulating early erythroid precursors that we intend to add to the list of CRCs. METHODS: We tested 15 healthy individuals that varied in age and gender employing a negative cell selection assay based on magnetic bead technology to characterize healthy adult circulating CD45 negative cell events using cell surface markers CD71 and glycophorin-A. RESULTS: Positive events were detected and varied in cell and nuclear size ranging between 7.5 µm till 15 µm and 4.5 till 9.2 µm, respectively with distinct appearance under bright field microscope. Cell rarity increased with cell and nuclear size. Largest cells exceeded 13.5 µm in cell diameter and were found in 7 out of 15 donors. CONCLUSIONS: Circulating erythroid precursors occur at different stages of maturation and may be part of the benign CRC spectrum.
BACKGROUND: Circulating rare cells (CRCs) are benign or malignant minuscule events in the peripheral blood or other bodily fluids. The detection and quantification of certain CRC types is an invaluable or proposed candidate biomarker for diagnosis, prognosis and prediction of various pathological conditions. The list of CRC types and biomarker applicability thereof continues to expand along with improvements in cell selection technology. Past findings may suggest commonness of healthy donor peripheral blood circulating mature erythroblasts. This work suggests the occurrence of morphologically distinct bone marrow native circulating early erythroid precursors that we intend to add to the list of CRCs. METHODS: We tested 15 healthy individuals that varied in age and gender employing a negative cell selection assay based on magnetic bead technology to characterize healthy adult circulating CD45 negative cell events using cell surface markers CD71 and glycophorin-A. RESULTS: Positive events were detected and varied in cell and nuclear size ranging between 7.5 µm till 15 µm and 4.5 till 9.2 µm, respectively with distinct appearance under bright field microscope. Cell rarity increased with cell and nuclear size. Largest cells exceeded 13.5 µm in cell diameter and were found in 7 out of 15 donors. CONCLUSIONS: Circulating erythroid precursors occur at different stages of maturation and may be part of the benign CRC spectrum.
Authors: Paolo Danise; Mariacaterina Maconi; Fabio Barrella; Anna Di Palma; Daniela Avino; Adele Rovetti; Maria Gioia; Giovanni Amendola Journal: Clin Chem Lab Med Date: 2011-10-25 Impact factor: 3.694
Authors: Steven W Purtle; Clare M Horkan; Takuhiro Moromizato; Fiona K Gibbons; Kenneth B Christopher Journal: Crit Care Date: 2017-06-21 Impact factor: 9.097
Authors: Fabio Fachin; Philipp Spuhler; Joseph M Martel-Foley; Jon F Edd; Thomas A Barber; John Walsh; Murat Karabacak; Vincent Pai; Melissa Yu; Kyle Smith; Henry Hwang; Jennifer Yang; Sahil Shah; Ruby Yarmush; Lecia V Sequist; Shannon L Stott; Shyamala Maheswaran; Daniel A Haber; Ravi Kapur; Mehmet Toner Journal: Sci Rep Date: 2017-09-07 Impact factor: 4.379
Authors: Mario Menk; Lena Giebelhäuser; Gerald Vorderwülbecke; Martina Gassner; Jan A Graw; Björn Weiss; Mathias Zimmermann; Klaus-D Wernecke; Steffen Weber-Carstens Journal: Ann Intensive Care Date: 2018-03-27 Impact factor: 6.925
Authors: Sara Puente-Marin; Iván Nombela; Sergio Ciordia; María Carmen Mena; Verónica Chico; Julio Coll; María Del Mar Ortega-Villaizan Journal: Genes (Basel) Date: 2018-04-09 Impact factor: 4.096
Authors: Lydia A Perkins; Lea Nyiranshuti; Lynda Little-Ihrig; Joseph D Latoche; Kathryn E Day; Qin Zhu; Sina Tavakoli; Prithu Sundd; Enrico M Novelli; Carolyn J Anderson Journal: Blood Adv Date: 2020-09-08